EDGAR·FLOW

Dare Bioscience, Inc. — Form 8-K

Filed October 2, 2026 · analyzed by the 8-K Agent
8-K ▼ Likely negative significance 92/100
What the filing says
On September 28, 2026, Dare Bioscience received notice of failure to satisfy continued listing standards, triggering Item 3.01 disclosure. The filing provides no details on which specific listing rule was breached, the exchange involved, cure period timeline, or remediation plan. This is a critical development for a $21.3M market-cap company.
Why this rating

Delisting notice is existential threat for micro-cap biotech; potential loss of public market access and liquidity is business-altering.

Extracted items
Tradability signal
SHORT conviction 57/100 · expected -2.73% over 4 hrs

SHORT (drift): bad news keeps sliding after dissemination — our one persistent measured edge. Similar past filings (53 in this cell) moved +4.02% in the called direction over 4 hrs; shrunk for sample size that's a +2.73% edge. Price is up 2.5% since the filing hit EDGAR — market hasn't digested it yet. Caution: sub-$5 shorts can be hard to borrow — treat as avoid-longs if no locate. Exit plan: HARD stop 5% against entry — default width (volatility unmeasured), fixed, not trailing (trails test terribly on these names) — time exit 4 hrs. (Filing arrived outside market hours — evaluated at the next open with a live quote.)

Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.

Price action (we called it negative)
before filing · preread
$0.84 ▼ 0.02%
at our read · unknown
$0.84
+10 min · unknown
$0.83 ▼ 1.01%
+30 min · unknown
$0.84 ▼ 0.17%
+1 hr · unknown
$0.85 ▲ 0.83%
+4 hrs · unknown
$0.84 ▼ 0.70%

The stock had already moved +0.02% between hitting EDGAR and our read finishing — deltas above are measured from our read.

Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →

View original filing on SEC.gov ↗ DARE · stock on Yahoo Finance ↗

See more from October 2, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.